Home > > Search result

Results: 1

Safety and immunogenicity of the RTS, S/AS02A candidate malaria vaccine in children aged 1–4 in Mozambique

Macete, E; Aponte, J. J; Guinovart, C; Sacarlal, J; Ofori-Anyinam, O; Mandomando, I; Espasa, M; Bevilacqua, C; Leach, A; Dubois, M C; Heppner, D G; Tello, L; Milman, J; Cohen, J; Dubovsky, F; Tornieporth, N; Thompson, R; Alonso, P. L.
Trop. med. int. health; 29 (1), 2007
The development of a malaria vaccine remains a public health priority for sub-Saharan Africa. RTS,S/AS02A candidate malaria vaccine has been shown to be safe and immunogenic in previous studies in adults and staggered dose-escalation studies in children in The Gambia. However, genetic features and the in...
Injections/adverse effects, Hepatitis/immunology, Malaria, Falciparum/epidemiology, Malaria Vaccines/immunology, Malaria/epidemiology, Mozambique/epidemiology
Fulltext